GPT and Hepatitis: The results of the current study suggest that the continuous BreathID®13C MBT is an accurate tool for identification of liver inflammation and fibrosis in patients with chronic HCV infection and normal ALT levels, and that its use can avoid the need for a liver biopsy in two-thirds of these patients.